mLST8 Promotes mTOR-Mediated Tumor Progression.
The activity of the mechanistic target of rapamycin (mTOR) is elevated in various types of human cancers, implicating a role in tumor progression. However, the molecular mechanisms underlying mTOR upregulation remain unclear. In this study, we found that the expression of mLST8, a required subunit o...
Main Authors: | Kyoko Kakumoto, Jun-Ichiro Ikeda, Masato Okada, Eiichi Morii, Chitose Oneyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4408021?pdf=render |
Similar Items
-
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01) -
The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.
by: Shunsuke Mori, et al.
Published: (2014-01-01) -
MiR-424/503-mediated Rictor upregulation promotes tumor progression.
by: Chitose Oneyama, et al.
Published: (2013-01-01) -
mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01) -
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
by: Tian Tian, et al.
Published: (2019-02-01)